Medications

Danish drugmaker reaches settlement with US authorities

Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2 diabetes.

Medications

EpiPen maker finalizes settlement for government overcharges

EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade—charges brought after rival Sanofi filed a whistleblower ...

Medications

US charges 412 people for health fraud, opioid scams

US authorities slapped 412 doctors, nurses and other medical professionals with fraud charges Thursday, many for overprescribing opioids that have stoked an expanding national addiction crisis.

Medications

Federal prosecutors accuse execs of fixing drug prices

Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended ...

page 6 from 11